Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ART-123 in Sepsis with DIC
NCT00487656Phase 2Completed
- Sponsor
- Artisan Pharma
- Start
- Jul 2007
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of thrombomodulin alfa in sepsis, disseminated intravascular coagulation (DIC), sponsored by Artisan Pharma. Started Jul 2007; status: completed.
02
Drugs
thrombomodulin alfa
03
Conditions
sepsisdisseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on NCT00487656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487656.